Patent ID: 11957785
Assignee: INTELGENX CORP.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 7:
8. An oral film dosage form providing transport of an agent for local delivery in a buccal cavity of a subject for at least two different agents for a sustained period of time, comprising:
(a) a disintegrable film;
(b) first solid polymer particles dispersed in the disintegrable film, the first solid polymer particles comprising a first mucoadhesive material exhibiting adhesivity to mucosa in the buccal cavity and a first active agent in the first solid polymer particles for release over a sustained period from the first mucoadhesive material; and
(c) second solid polymer particles dispersed in the disintegrable film, the second solid polymer particles comprising a second mucoadhesive material exhibiting adhesivity to mucosa in the buccal cavity that is different from the first mucoadhesive material and a second active agent contained in the second solid polymer particles that is the same as or different from the first active agent and is released over a sustained period from the second mucoadhesive material, wherein at least one of the first and second active agents is a cannabis extract, cannabis oil, tetrahydrocannabinol (THC), THC complexed with cyclodextrin (CD), cannabidiol (CBD), or a THC/CBD combination, wherein the disintegrable film exhibits lower mucoadhesivity than the mucoadhesive particles.